Abstract
The rapid diffusion of novel psychoactive substances NPS presents unprecedented legislative and policy challenges to the current drug control regimes and national legislation. This contribution provides a comprehensive assessment of the current legislative responses to NPS while providing new insights on the potential of a functional-based legal approach in the regulated market, modelled after the UK Human Medicines Regulations 2012. The overall analysis will focus on examining how current legal and policy responses have failed to respond to the NPS challenge and advancing a ‘functionalist’ legislative solution to the NPS challenge as an alternative to existing prohibitionist framework based on a deficient notion of psychoactivity. It argues how a wide legal definition of NPS combined with reactive legal responses and the diffusion of NPS in the more hidden deep and dark Web contribute to unintended health and criminal consequences. It argues in favour of a more practicable and accountable regulatory regime supported by a specialized NPS Authority.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Advisory Council on the Misuse of Drugs (2015) ACMD report on definitions for the psychoactive substances bill, August 17. https://www.gov.uk/government/publications/acmd-report-on-definitions-for-the-psychoactive-substances-bill
Alexa (2013) The top 500 sites on the web. http://www.alexa.com/topsites/global. Accessed Oct 2016
Al-Imam A, Santacroce R, Roman-Urrestarazu A, Chilcott R, Bersani G, Martinotti G, Corazza O (2016) Captagon: use and trade in the Middle East. Hum Psychopharmacol Clin Exp. doi:10.1002/hup.2548
Barratt MJ, Ferris JA, Winstock AR (2013) Use of silk road, the online drug marketplace, in the United Kingdom. Addiction, Australia and USA
Bergman MK (2001) White paper: the deep web: surfacing hidden value. J Electron Publ 7(1). doi:10.3998/3336451.0007.104
Cicero TJ, Ellis MS (2012) Health outcomes in patients using no-prescription online pharmacies to purchase prescription drugs. J Med Internet Res 14(6):e174
Corazza O, Roman-Urrestarazu A (2015) Evidence on novel psychoactive substances bill. Submitted to the Members of Public Bill Committee, House of Commons, 22 Oct 2015 (PSB 17)
Corazza O, Schifano F, Farre M, Deluca P, Davey Z, Drummond C, Torrens M, Demetrovics Z, Di Furia L, Flesland L, Mervo B, Moskalewicz J, Pisarska A, Shapiro H, Siemann H, Skutle A, Pezzolesi C, Van Der Kreeft P, Scherbaum N (2011) Designer drugs on the internet: a phenomenon out-of-control? The emergence of hallucinogenic drug bromo-dragonfly. Curr Clin Pharmacol 6:125–129
Corazza O, Assi S, Simonato P, Corkery J, Bersani FS, Demetrovics Z, Stair J, Fergus S, Pezzolesi C, Pasinetti M, Deluca P, Drummond C, Davey Z, Blaszko U, Moskalewicz J, Mervo B, Furia LD, Farre M, Flesland L, Pisarska A, Shapiro H, Siemann H, Skutle A, Sferrazza E, Torrens M, Sambola F, van der Kreeft P, Scherbaum N, Schifano F (2013) Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Hum Psychopharmacol 28(4):317–323
Corazza O, Simonato P, Corkery J, Trincas G, Schifano F (2014) “Legal highs”: safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Rivista di Psichiatria 49(2):89–94
Corazza O, Chan HY, Collins J, Soderholm A, Roman-Urrestarazu A (2017) From prohibition to regulation’: managing the novel psychoactive substances’ challenge with innovative policy responses. Addictions (under submission)
Davey Z, Schifano F, Corazza O, Deluca P, Psychonaut Web Mapping Group (2012) e-Psychonauts: conducting research in online drug forum communities. J Ment Health 21(4):386–394
Deluca P, Davey Z, Corazza O, Di Furia L, Farre M, Flesland LH, Mannonen M, Majava A, Peltoniemi T, Pasinetti M, Pezzolesi C, Scherbaum N, Siemann H, Skutle A, Torrens M, van der Kreeft P, Iversen E, Schifano F (2012) Identifying emerging trends in recreational drug use; outcomes from the Psychonaut web mapping project. Prog Neuro-Psychopharmacol Biol Psychiatry 39(2):221–226
EMCDDA-Europol (2009) On the implementation of Council Decision 2005/387/JHA annual report
Evans-Brown M, McVeigh J, Perkins C, Bellis M (2012) Human enhancement drugs: the emerging challenges to public health. Centre for Public Health, Liverpool John Moores University, UK
Forman RF, Marlowe DB, McLellan AT (2006) The Internet a source of drugs of abuse. Curr Psych Rep 8(5):377–382
Franklin D (2012) Drug detectives. Physicians struggle to curb the growing number of lethal overdoses. Sci Am 307(4):30–321
Gallagher J, Collaizi J (2000) Issues in Internet pharmacy practice. Ann Pharmacother 34(12):1438–1445
González D, Riba J, Bouso JC, Gómez Jarabo G, Barbanoj MJ (2006) Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 85:157–162
Griffiths P, Sedefov R, Gallegos ANA, Lopez D (2010) How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case study. Addiction 105:951–953
Hughes B, Winstock AR (2012) Controlling new drugs under marketing regulations. Addiction 107:1894–1899
Kanayama G, Hudson JI, Pope HG (2012) Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom 81(2):73–78. doi:10.1159/000330415
King LA, Kicman AT (2011) A brief history of ‘new psychoactive substances’. Drug Test Anal 3:401–403
Konrad A (2013) Feds say they’ve arrested ‘Dread Pirate Roberts,’ shut down his black market ‘The Silk Road’. Forbes, 2 Oct 2013
Kosinski M, Stillwell D, Graepel T (2012) Private trace and attributes are predicable from digital records of human behavior. Proc Natl Acad Sci U S A 110(15):5802–5805. doi:10.1073/pnas.1218772110
Lange JE, Daniel J, Homer K, Reed MB, Clapp JD (2010) Salvia divinorum: effects and use among YouTube users. Drug Alcohol Depend 108(1–2):138–140
Lowes R (2000) Are online pharmacies good for your patient – and for you? Med Econ 77(84–86):77–80
Mackey TK, Liang BA (2013) Global reach of direct-to-consumer advertising using social media for illicit online drug sales. J Med Internet Res 15(5):e105
MixMag’s Global Drug Survey (2013) The results. http://www.mixmag.net/words/features/mixmags-global-drug-survey-the-results. Accessed 18 Apr 2017
National Center on Addiction and Substance Abuse at Columbia University (CASA) (2012) National survey of American attitudes on substance abuse XVII: Teens. http://www.centeronaddiction.org
Newton NC, Vogl L, Teesson M, Andrews G (2011) Developing the climate schools: alcohol and cannabis module: a harm-minimization, universal drug prevention program facilitated by the Internet. Subst Use Misuse 46(13):1651–1663
Orizio G, Shulz P, Domenighini S, Caimi L, Rosati C, Rubinelli S (2010) Cyberdrugs: a cross-sectional study of online pharmacies and the enhancement of peripheral thinking in consumers. Pharmacoepidemiol Drug Saf 19(9):970–976
RAND (Europe) (2016) The role of the ‘dark’ web in the illicit drug market. Res Brief. www.rand.org. Accessed 02 Feb 2017
Randewich N (2013) New silk road drug bazaar opens a month after FBI bust. Reuters. http://www.webcitation.org/6LTdCZBP7. Accessed 7 Nov 2013
Reuter P, Pardo B (2016) Can new psychoactive substances be regulated effectively? An assessment of the british psychoactive substances bill. Addiction 112(1):25–31. doi:10.1111/add.13439
Santacroce R, Sarchione F, Corazza O, Lupi M, Cinosi E, Di Giannantonio M, Martinotti G (2016) P.6.d.016 – The art of being smart: cognitive enhancement in a population of Italian university students. Eur Neuropsychopharmacol 26(Suppl 2):S697–S698
Seddon T (2014) Drug policy and global regulatory capitalism: the case of new psychoactive substances (NPS). Int J Drug Policy 25(5):1019–1024
Singleton N, Rubin J (2014) What is good governance in the context of drug policy? Int J Drug Policy 25(5):935–941
Smith SD, Salaway G, Caruso JB (2009) The ECAR study of undergraduate students and information technology, 2009. Educause Center for Applied Research, Boulder, CO
Stevens A, Rudi F, Measham F, Sumnall H (2015) Legally flawed, scientifically problematic, potentially harmful: the UK psychoactive substance bill. Int J Drug Policy 26(12):1167–1170. doi:10.1016/j.drugpo.2015.10.005
Sumnall HR, Evans-Brown M, McVeigh J (2011) Social, policy, and public health perspectives on new psychoactive substances. Drug Test Anal 3(7–8):515–523
Van Amsterdam J, Nutt D, van den Brink W (2013) Generic legislation of new psychoactive drugs. J Psychopharmacol 27:317–324
Van Hout MC, Bingham T (2013) ‘Silk Road’, the virtual drug marketplace: a single case study of user experiences. Int J Drug Policy 24(5):385–391
Van Hout MC, Bingham T (2014) Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. Int J Drug Policy 25(2):183–189
Walsh C (2011) Drugs, the Internet and change. J Psychoactive Drugs 43(1):55–63
YouTube (2013) Statistics of YouTube use. http://www.youtube.com/yt/press/statistics.html. Accessed 17 Dec 2013
YouTube (2014a) Legal high guy reviews. http://www.youtube.com/playlist?list=PLA28147DEF2673B0B. Accessed 2 May 2016
YouTube (2014b) Neurosoup: drug education and harm reduction. http://www.youtube.com/user/NeuroSoup. Accessed 2 May 2016
YouTube (2017) Community guidelines. A few ground rules to keep the YouTube safe and sun for everyone. https://www.youtube.com/yt/policyandsafety/communityguidelines.html. Accessed 25 Mar 2017
Zuckerberg M (2012) One billion people on Facebook. http://newsroom.fb.com/News/457/One-Billion-People-on-Facebook. Accessed Mar 2017
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Corazza, O., Chan, H.Y., Roman-Urrestarazu, A. (2017). NPS: Moving from Blanket Prohibition to a Functionalist Approach. In: Corazza, O., Roman-Urrestarazu, A. (eds) Novel Psychoactive Substances. Springer, Cham. https://doi.org/10.1007/978-3-319-60600-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-60600-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60599-9
Online ISBN: 978-3-319-60600-2
eBook Packages: MedicineMedicine (R0)